Use of EP2 selective receptor agonists in medical treatment
Provided is the use of a prostaglandin E2 receptor subtype EP2 selective receptor agonist compound belonging to a specified class of compounds in the manufacture of a medicament for treating avascular necrosis, including use of the compound (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-met...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.06.2008
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is the use of a prostaglandin E2 receptor subtype EP2 selective receptor agonist compound belonging to a specified class of compounds in the manufacture of a medicament for treating avascular necrosis, including use of the compound (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid. |
---|---|
Bibliography: | Application Number: NZ20040541828 |